Kavita Patel, a director at $ACLX, sold 1,500 shares of the company on 03-18-2025 for an estimated $107,460. We received data on the trade from a recent SEC filing. This was a sale of approximately 100.0% of their shares of this class of stock. Following this trade, they now own 0 shares of this class of $ACLX stock.
$ACLX Insider Trading Activity
$ACLX insiders have traded $ACLX stock on the open market 54 times in the past 6 months. Of those trades, 0 have been purchases and 54 have been sales.
Here’s a breakdown of recent trading of $ACLX stock by insiders over the last 6 months:
- KAVITA PATEL has made 0 purchases and 21 sales selling 69,479 shares for an estimated $6,916,963.
- RAMI ELGHANDOUR (SEE REMARKS) has made 0 purchases and 7 sales selling 97,244 shares for an estimated $6,884,355.
- MICHELLE GILSON (CHIEF FINANCIAL OFFICER) has made 0 purchases and 17 sales selling 57,728 shares for an estimated $4,750,961.
- CHRISTOPHER HEERY (CHIEF MEDICAL OFFICER) has made 0 purchases and 9 sales selling 30,662 shares for an estimated $2,226,679.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$ACLX Hedge Fund Activity
We have seen 111 institutional investors add shares of $ACLX stock to their portfolio, and 94 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FMR LLC added 1,477,360 shares (+22.8%) to their portfolio in Q4 2024, for an estimated $113,298,738
- RA CAPITAL MANAGEMENT, L.P. added 935,848 shares (+50.5%) to their portfolio in Q4 2024, for an estimated $71,770,183
- VANGUARD GROUP INC added 867,996 shares (+35.3%) to their portfolio in Q4 2024, for an estimated $66,566,613
- SUVRETTA CAPITAL MANAGEMENT, LLC removed 689,950 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $52,912,265
- JANUS HENDERSON GROUP PLC removed 454,858 shares (-22.6%) from their portfolio in Q4 2024, for an estimated $34,883,060
- PERCEPTIVE ADVISORS LLC removed 409,781 shares (-10.5%) from their portfolio in Q4 2024, for an estimated $31,426,104
- BLACKROCK, INC. removed 392,671 shares (-9.2%) from their portfolio in Q4 2024, for an estimated $30,113,938
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$ACLX Analyst Ratings
Wall Street analysts have issued reports on $ACLX in the last several months. We have seen 7 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Benchmark issued a "Positive" rating on 12/09/2024
- Bank of America Securities issued a "Buy" rating on 12/09/2024
- Piper Sandler issued a "Overweight" rating on 11/08/2024
- Citigroup issued a "Buy" rating on 11/06/2024
- H.C. Wainwright issued a "Buy" rating on 11/06/2024
- Evercore ISI issued a "Outperform" rating on 10/29/2024
- Needham issued a "Buy" rating on 10/18/2024
To track analyst ratings and price targets for $ACLX, check out Quiver Quantitative's $ACLX forecast page.
$ACLX Price Targets
Multiple analysts have issued price targets for $ACLX recently. We have seen 5 analysts offer price targets for $ACLX in the last 6 months, with a median target of $115.0.
Here are some recent targets:
- Biren Amin from Piper Sandler set a target price of $115.0 on 11/08/2024
- Jack Allen from Robert W. Baird set a target price of $106.0 on 11/06/2024
- Emily Bodnar from H.C. Wainwright set a target price of $95.0 on 11/06/2024
- Cory Kasimov from Evercore ISI set a target price of $120.0 on 10/29/2024
- Ben Burnett from Stifel Nicolaus set a target price of $122.0 on 10/18/2024
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
